RBR-7chtrj招募中未知
Augmenting pharmacological treatment of treatment-resistant social anxiety disorder with cognitive therapy
Instituto de Psiquiatria da UFRJ - IPUB0 个研究点开始时间: 2017年9月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 70Y（—）
入选标准
- •A current principal diagnosis of social anxiety disorder by DSM-5 criteria; A history of at least one unsuccessful adequate pharmacological treatment trials, operationalized as lack of response Clinical Global Impression-improvement scale (CGI-I) greater than or equal to 3, to at least 10 weeks of (i) SSRIs or venlafaxine at adequate dosage; with or without (ii) benzodiazepines (e.g. clonazepam 2 mg/day); A total score on the Liebowitz Social Anxiety Scale (LSAS) of 50 or greater; Man and woman with age of at least 18 years.
排除标准
- •Pregnancy, lactation, and women of childbearing potential without accepted forms of contraception; Psychotic disorders, bipolar disorder, mental retardation, a recent history of alcohol or substance abuse or dependence; Severe organic medical disorder; Concurrent use of other psychotropic medications than detailed in inclusion criteria; Current or recent significant suicidality; Any concurrent psychotherapy
研究者
相似试验
招募中
不适用
Pharmaceutical-pharmacological interventions to improve drug therapy safety of inpatient carelow adherence, problems with drug application/use, patients' concerns regarding their drug therapyDRKS00026088Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik100
已完成
2 期
Effect of add-on medication (with dose increase, combined with anti-leukotriene , combined with steroid nasal spray)for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate .allergic rhinitisJPRN-UMIN000011336Graduate Scool of Medicine150
已完成
不适用
Providing therapy with dose administration aids and existing cardiovascular medicines - PilotMedication adherenceCardiovascular - Other cardiovascular diseasesPublic Health - Other public healthCardiovascular diseaseACTRN12620001239954The George Institute for Global Health100
进行中（未招募）
1 期
Pharmacologic treatment augmentation in chronic depressionrandomized, controlled, double blinded, phase II studyMales and females between 18-64 years with a diagnosis ofchronic depressionMedDRA version: 21.1Level: LLTClassification code 10066555Term: Chronic depressionSystem Organ Class: 100000004873EUCTR2019-001692-37-DEniversity Hospital Tuebingen60
招募中
1 期
Pharmacologic treatment augmentation in chronic depressionrandomized, controlled, double blinded, phase II study”Diagnosis of chronic depressionMedDRA version: 21.1Level: LLTClassification code: 10066555Term: Chronic depression Class: 10037175CTIS2024-512478-86-00niversitaetsklinikum Tuebingen AöR60